Real-world BCLC adherence and survival in hepatocellular carcinoma: first prospective study from Central America Pablo Coste Murillo; María Fernanda Lynch-Mejía; Wagner Ramírez Quesada; Francisco Vargas Navarro; Vanessa López Jara; Silvia Alfaro Cartín; Ariela Gómez Pérez; Sheila Araya Chavarría; Fabián Araya Madriz; Esteban González González; Irene Mora Quesada; Alejandra Ochoa Palominos; Karen Melissa Rodríguez Masís;

Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;

Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies Jui-Hsiang Hung; Chiao-Feng Teng; Hsu-chin Hung; Yi-Lin Chen; Pin-Jun Chen; Chung-Liang Ho; Cheng-Hsiang Chuang; Wenya Huang;